Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Sep 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Lisdexamfetamin, Atc N06ba12 (obg) Für Die Zeit 01.08.24 - 31.07.25 (zzgl. Verlängerungsoption 1x12 Monate)
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Dec 2024
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Sofosbuvir Und Velpatasvir, Atc J05ap55 Für Die Zeit 01.05.2024 - 30.04.2026
Closing Date5 Mar 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 Sgb V for the active ingredient trientine, Atc A16ax12 for the period May 1st, 2024 - April 30th, 2026
Closing Date5 Mar 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Alirocumab, Atc C10ax14 For The Time 01.06.2023 - 31.05.2025
Closing Date5 Apr 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 Sgb V for the active ingredient allergen extract from birch pollen, Atc V01aa05 for the period November 1st, 2023 - October 31st, 2025 (1004065 - Allergen extract from birch pollen, Atc V01aa05)
Closing Date5 Sep 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Meropenem, Atc J01dh02 Für Die Zeit 01.03.2024 - 28.02.2026
Closing Date5 Jan 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Aug 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient Raltegravir, Atc J05ax08 for the period November 1st, 2023 - October 31st, 2025
Closing Date5 Sep 2025
Tender AmountRefer Documents 
1-10 of 342 active Tenders